Anika Reports First Quarter Fiscal 2022 Financial Results
May 05, 2022 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 15, 2022 17:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on April 1,...
Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
April 07, 2022 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
April 04, 2022 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting
March 23, 2022 08:30 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2022 19:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it granted: ...
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
March 10, 2022 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Reports Fourth Quarter and Year-End 2021 Financial Results
March 08, 2022 16:05 ET
|
Anika Therapeutics Inc.
Fourth quarter revenue growth of 10% year-over-year despite COVID headwindsFull-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08, 2022 ...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 11, 2022 18:50 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on February 1,...
Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
February 08, 2022 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...